- Home
- CUE vs AXIL Comparison
CUE vs AXIL Comparison
Compare CUE & AXIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- AXIL
- Stock Information
- Founded
- CUE 2014
- AXIL 2015
- Country
- CUE United States
- AXIL United States
- Employees
- CUE N/A
- AXIL N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- AXIL Package Goods/Cosmetics
- Sector
- CUE Health Care
- AXIL Consumer Discretionary
- Exchange
- CUE Nasdaq
- AXIL Nasdaq
- Market Cap
- CUE 57.7M
- AXIL 52.6M
- IPO Year
- CUE 2018
- AXIL N/A
- Fundamental
- Price
- CUE $0.74
- AXIL $8.84
- Analyst Decision
- CUE Strong Buy
- AXIL
- Analyst Count
- CUE 3
- AXIL 0
- Target Price
- CUE $3.00
- AXIL N/A
- AVG Volume (30 Days)
- CUE 510.6K
- AXIL 17.9K
- Earning Date
- CUE 08-13-2025
- AXIL 08-14-2025
- Dividend Yield
- CUE N/A
- AXIL N/A
- EPS Growth
- CUE N/A
- AXIL 93.65
- EPS
- CUE N/A
- AXIL 0.29
- Revenue
- CUE $7,991,000.00
- AXIL $27,007,463.00
- Revenue This Year
- CUE N/A
- AXIL N/A
- Revenue Next Year
- CUE $23.84
- AXIL N/A
- P/E Ratio
- CUE N/A
- AXIL $30.63
- Revenue Growth
- CUE 13.83
- AXIL N/A
- 52 Week Low
- CUE $0.45
- AXIL $3.54
- 52 Week High
- CUE $1.99
- AXIL $10.75
- Technical
- Relative Strength Index (RSI)
- CUE 43.63
- AXIL 80.77
- Support Level
- CUE $0.84
- AXIL $8.15
- Resistance Level
- CUE $0.90
- AXIL $8.85
- Average True Range (ATR)
- CUE 0.10
- AXIL 0.79
- MACD
- CUE -0.02
- AXIL 0.26
- Stochastic Oscillator
- CUE 11.27
- AXIL 99.67
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About AXIL AXIL Brands Inc. Common Stock
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering.